2m 2m 2m 2m 2m 2m 2m
CORMEDIX (CRMD)
NASDAQ
$8.73+$0.13 (+1.50%)
Price as of Jun 23, 2026 6:27 PM EDT- $691.9MMarket Cap
- -45.29%1-Year Change
- BiotechnologyIndustry
CORMEDIX (CRMD)
$8.73+$0.13 (+1.50%)
CRMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.60 | ||
Change | +$0.15 (+1.73%) | ||
Open | $8.75 | ||
High | $8.96 | ||
Low | $8.60 | ||
Previous Close | $8.82 | ||
Volume | 1,272,538 | ||
30-Day Average Volume | 1,303,655 | ||
1-Week Change | 2.68% | ||
1-Month Change | 10.53% | ||
1-Year Change | -46.74% | ||
3-Year Change | 55.01% | ||
5-Year Change | 16.05% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $815.6M | ||
Market Cap | $691.9M | ||
Enterprise Value | $513.9M | ||
Period: QTR TTM FY | |||
Revenue | $121.9M | ||
Net Income | $38.6M | ||
Free Cash Flow | $41.7M | ||
EBIT | $55.6M | ||
EBITDA | $66.2M | ||
Net Working Capital | $254.3M | ||
EPS | $0.43 | ||
Enterprise Value/EBITDA | 8 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | 21 | ||
PEG | 0 | ||
Price/Free Cash Flow | 17 | ||
Price/Operating Cash Flow | 16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 03/26/2019 | ||
Earnings & Revenue